A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Fielmann Group AG's Debt-to-EBITDA or its related term are showing as below:
XSWX:FIE'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.01 Med: 1.3 Max: 2.38
Current: 1.82
During the past 13 years, the highest Debt-to-EBITDA Ratio of Fielmann Group AG was 2.38. The lowest was 0.01. And the median was 1.30.
XSWX:FIE's Debt-to-EBITDA is ranked worse than 55.11% of 470
companies
in the Medical Devices & Instruments industry
Industry Median: 1.585
vs XSWX:FIE: 1.82
Fielmann Group AG (XSWX:FIE) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Fielmann Group AG Debt-to-EBITDA Related Terms
Fielmann Group AG Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Fielmann Group AG's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FIE vs ISRG, BDX, MDLN: Debt-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Fielmann Group AG (XSWX:FIE) has a Debt-to-EBITDA of 0.00 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Fielmann Group AG. Over the past decade, Fielmann Group AG's Debt-to-EBITDA has ranged from 0.01 to 2.38. According to the industry distribution chart, Fielmann Group AG ranks #259 out of 470 companies in the Medical Devices & Instruments industry, placing it in the top 55.1%.
Is Fielmann Group AG's Debt-to-EBITDA too high?
Fielmann Group AG's current Debt-to-EBITDA is 0.00. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 2.38. Based on the distribution chart, Fielmann Group AG ranks #259 out of 470 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Fielmann Group AG has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's Debt-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #259 out of 470 companies for Debt-to-EBITDA. This places Fielmann Group AG in the lower half of its industry. The industry median Debt-to-EBITDA is 1.59. Historically, Fielmann Group AG's own Debt-to-EBITDA has ranged from 0.01 to 2.38 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.59, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Fielmann Group AG. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current Debt-to-EBITDA is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current Debt-to-EBITDA of 0.00. The stock's GF Value™ is CHF50.78, compared to a current price of CHF38.70 — trading 23.8% below its estimated fair value. The current Debt-to-EBITDA is 0.00. Fielmann Group AG's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current Debt-to-EBITDA is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF38.70 is trading 23.8% below its estimated GF Value™ of CHF50.78.
Key valuation signals for XSWX:FIE:
Debt-to-EBITDA: 0.00
GF Value™: CHF50.78 vs. price of CHF38.70 (23.8% below fair value)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
78GF Score
Get the complete analysis for XSWX:FIE
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
